Scopus BioPharma Inc. (SCPS) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19
	10-K	10-K	10-K
Revenues	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0
Selling, general and administrative [+]	12.6	2.7	2.2
General and administrative	12.6	2.7	2.2
Research and development	15.0	7.4	0.5
EBITDA [+]	-27.6	-10.2	-2.7
EBITDA growth	172.1%	277.6%
Depreciation and amortization	0.0	0.0	0.0
EBIT [+]	-27.6	-10.2	-2.7
EBIT growth	172.1%	277.5%
Interest expense	0.8	0.7
Interest expense	0.8	0.7
Other income (expense), net [+]	1.5
Change in fair value of warrants	1.5
Other	0.7	-0.7
Pre-tax income	-27.0	-10.9	-2.7
Income taxes	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%
Net income	-27.0	-10.9	-2.7

Basic EPS [+]	($1.56)	($0.81)	($0.22)
Growth	92.2%	263.3%
Diluted EPS [+]	($1.56)	($0.81)	($0.22)
Growth	92.2%	263.3%

Shares outstanding (basic) [+]	17.3	13.4	12.0
Growth	29.1%	11.2%
Shares outstanding (diluted) [+]	17.3	13.4	12.0
Growth	29.1%	11.2%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.